Wang, Tao
Song, Dan
Li, Xuejuan
Luo, Yu
Yang, Dianqiang
Liu, Xiaoyan
Kong, Xiaodan
Xing, Yida
Bi, Shulin
Zhang, Yan
Hu, Tao
Zhang, Yunyun
Dai, Shuang
Shao, Zhiqiang
Chen, Dahan
Hou, Jinpao
Ballestar, Esteban
Cai, Jianchun
Zheng, Feng
Yang, James Y.
Funding for this research was provided by:
Postdoctoral Fellowship
National Key R&D Program of China (2020YFC2005002)
National Natural Science Foundation of China (81970642)
Key research and development grant, the Department of Science and Technology, Liaoning, China
Innovative Leading Researcher grant, the Department of Science and Technology, Dalian, China
The 973 Program of China (2015CB553800)
Article History
Received: 26 December 2023
Accepted: 28 March 2024
First Online: 8 April 2024
Declarations
:
: J.Y.Y., T.W., Y.L, J.C. and F.Z. are the authors on a Patent Cooperation Treaty application entitled “Uses of miRNA miR-574-5p-based compounds as immunomodulators and compositions thereof”, filed by Amoigen Bioscience (Xiamen) Company Limited Xiamen, China. (PCT/CN2015/094617).
: J.Y.Y., T.W., Y.L, J.C. and F.Z. are the authors on a Patent Cooperation Treaty application entitled “Uses of miRNA miR-574-5p-based compounds as immunomodulators and compositions thereof”, filed by Amoigen Bioscience (Xiamen) Company Limited Xiamen, China. (PCT/CN2015/094617)